Operating Lease, Right-of-Use Asset of Calidi Biotherapeutics, Inc. from 30 Sep 2022 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Calidi Biotherapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 30 Sep 2022 to 30 Sep 2025.
  • Calidi Biotherapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $2,012,000, a 38% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Calidi Biotherapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $2,012,000 -$1,225,000 -38% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $2,333,000 -$1,185,000 -34% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $2,636,000 -$1,162,000 -31% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $2,934,000 -$1,139,000 -28% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 $3,237,000 -$1,094,000 -25% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $3,518,000 -$1,058,000 -23% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $3,798,000 -$1,029,000 -21% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $4,073,000 +$3,874,000 +1947% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $4,331,000 +$4,138,000 +2144% 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $4,576,000 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 $4,827,000 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q4 2022 $199,000 31 Dec 2022 10-K 15 Mar 2024 2023 FY
Q3 2022 $193,000 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.